Boston Scientific, Inc. BSX recently obtained a CE Mark on the Vercise Neural Navigator 5 Software with STIMVIEW XT technology. When used as an element of the Vercise Genus Deep Brain Stimulation (DBS ...

Abbott Laboratories (NYSE:ABT) received FDA approval to launch the Liberta RC DBS system, the world’s smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people ...

GUIDE DBS is the World's First Deep Brain Stimulation Visual Simulation System NATICK, Mass., Boston Scientific Corporation has received CE Mark approval for use of the GUIDE™ DBS System, the world's ...

The digitization of implanted devices continues apace. On Monday, Abbott announced the launch of its FDA-approved NeuroSphere Virtual Clinic by which patients implanted with the company’s deep brain ...

Remote DBS programming improved Parkinson symptoms faster and reduced travel burdens, expanding access to specialized care.

The FDA has approved an expanded indication for the Infinity™ Deep Brain Stimulation (DBS) system (Abbott) to include targeting the internal globus pallidus, which may lead to symptom improvement in ...

This First-of-its-Kind Directional Lead Combines the Benefits of Directionality with the Power of Sensing "This is the only directional lead with built-in sensing capabilities," said Jens Volkmann, ...

The US Food and Drug Administration (FDA) has approved a new software upgrade for Abbott's Infinity deep-brain stimulation (DBS) system used in patients with Parkinson's disease and essential tremor, ...

The US Food and Drug Administration (FDA) has approved the first adaptive deep brain stimulation (aDBS) system for Parkinson’s disease (PD) that self-adjusts therapy to individual brain activity in ...

This First-of-its-Kind Directional Lead Combines the Benefits of Directionality with the Power of Sensing DUBLIN, March 22, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical ...